Familial hypercholesterolemia: Identification and molecular characterization of the first compound homozygous patient in Spain;Hipercolesterolemia familiar: Identificación y caracterización molecular del primer homozigoto compuesto Español

Medicina Clinica

Volumn 110, Issue 8, 1998, Pages 300-302

  Chaves, Francisco J ^a   Real, José T ^b   Puig, Óscar ^a   Ascaso, Juan F ^b   Teruel, José L ^c   Lasuncion, Miguel A ^c   Carmena, Rafael ^b   Armengod, María E ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CASE REPORT; FEMALE; GENETICS; HOMOZYGOTE; HUMAN; HYPERCHOLESTEROLEMIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SPAIN;

ADULT; DNA; FEMALE; HOMOZYGOTE; HUMANS; HYPERCHOLESTEROLEMIA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SPAIN;

EID: 0032492292     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Brown MS, Goldstein JL A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
2. Hobbs H, Russel D, Brown MS, Goldstein JL. The LDL receptor locus in familial hypercholesterolemia: mutation analysis of a membrane protein. Annu Rev Genet 1990; 24: 133-170.
3. Varret M, Rabès JP, Collod-Béroud G, Junien C, Boileau C, Bèroud C. Software and database for the analysis of mutations in the LDL receptor gene. Nucleic Acids Res 1997; 25: 172-180.
4. Hobbs H, Brown MS, Golstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992; 1: 445-466.
5. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphism of human DNA by gel electrophoresis as single-strand conformational polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2.766-2.770.
6. Lasunción MA, Teruel JL, Álvarez JJ, Carrero P, Ortuño J, Gómez-Coronado D. Changes in lipoprotein (a), LDL cholesterol and apolipoprotein B in homozygous familial hypercholesterolemic patients treated with dextran sulfate LDL-apheresis. Eur J Clin Invest 1993; 23: 819-826.
7. Lasunción MA, Teruel JL, Álvarez JJ, Gómez-Coronado D, Ortuño J, Herrera E. Lipoproteína (a) en suero durante el tratamiento con aféresis de LDL en la hipercolesterolemia familiar homozigótica. Med Clin (Barc) 1992; 99: 541-544.
8. Teruel JL, Lasunción MA, Navarro JF, Carrero P, Ortuño J. Pregnancy in a patient with homozigous familial hypercholesterolemia undergoing LDL-apheresis by dextran sulphate adsorption treatment. Metabolism 1995; 44: 929-933.
9. Beidler JL, Hilliard PR, Rill RL. Ultrasensitive staining of nucleid acids with silver. Anal Biochem 1982; 126: 374-380.
10. Zimmermann J, Voss H, Erfle H, Rupp T, Dietrich NA, Hewitt C et al. Cycle sequencing protocol with fluorescein-12-dUTP for M13, plasmid and cosmid DNA. Methods Mol Cell Biol 1992; 3: 146-148.
11. Illingworth DR. How effective is drug therapy in heterozygous familial hypercholesterolemia. Am J Cardiol 1993; 72: 54-58.
12. Uauy R, Zwiener RJ, Phillips MJ, Petruska ML, Bilheimer DW. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis. J Pediatr 1992; 120: 892-898.
13. Teruel JL, Lasunción MA, Castañón MA, Gallego N, Herrera E, Ortuño J. Tratamiento de la hipercolesterolemia familiar homozigótica con aféresis continua de lipoproteínas de baja densidad. Med Clin (Barc) 1991; 97: 738-740.
14. Grossmann M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ et al. A pilot study of ex vivo therapy for homozygous familial hypercholesterolemia. Nat Med 1995; 1: 1.148-1.154.
15. Wilson JM, Grossman M. Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer. Am J Cardiol 1993; 72: 59-63.
16. Südhof TC, Goldstein JL, Brown MS, Russell DW. The LDL receptor gene: a mosaic of exons shared with different proteins Science 1983; 228: 815-822.
17. Hayasi K. PCR-SSCP: a simple and sensitive method for detection of mutations in genomic DNA. PCR Methods Applic 1991; 1: 34-48.
18. Hayasi K, Yandell DW. How sensitive is PCRSSCP? Hum Mut 1993; 2: 338-346
19. Chaves JF, Puig O, Garcia-Sogo M, Real J, Gil JV, Ascaso JF et al. Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain. Clin Genet 1996; 50: 28-35.
20. Chaves JF, Puig O, Garcia-Sogo M, Real J, Armengod ME. A three allelic polymorphic system in exon 12 of LDL receptor gene is highly informative for segregation analysis of familial hypercholesterolemia in the Spanish population. Clin Genet 1996; 50: 50-53.
21. Kotze MJ, Langenhoven E, Theart L, Marx MP, Oosthuizen CJ. Report on a molecular diagnostic service for familial hypercholesterolemia in Afrikaners. Genet Couns 1994; 5: 15-21.
22. Coviello DA, Bertolini S, Masturzo P, Ghisellini M, Tiozzo R, Zambelli F et al. Chorionic DNA analysis for the prenatal diagnosis of familial hypercholesterolemia. Hum Genet 1993; 92: 424-426.
23. Vogt TM. Risk assessment and health hazard appraisal. Ann Rev Public Health 1981; 2: 31-47.
24. Quaid KA. Psychological and ethical considerations in screening for disease. Am J Cardiol 1993; 72: 64-67.
25. Lazo PA. Terapia génica humana: tendencias y problemas actuales. Med Clin (Barc) 1996; 106: 469-476.